BUSINESS

• Humira Biosimilar Grabs European Panel Backing: Fujifilm Kyowa Kirin/Mylan
  July 31, 2018

• Daiichi Sankyo Inks ADC License Pact with Glycotope
  July 31, 2018

• Ono Seeks Add’l Indication for Onoact in Ventricular Arrhythmia
  July 31, 2018

• Fujifilm to Shutter Gx, LLP Operations in March
  July 30, 2018

• Mitsubishi Tanabe’s Erythropoietic Protoporphyria Earns FDA Fast-Track Status
  July 30, 2018

• Chugai Forms Partnership with AI Upstart
  July 30, 2018

• Chugai to Construct New Synthetic Research Building at Ukima Lab
  July 30, 2018

• Chugai to Extend Operation Period of Singapore Research Subsidiary
  July 30, 2018

• AI in Pharma - 1: Companies Going Digital in Sales Support but Still Embrace Rep Experience
  July 30, 2018

• Chugai Filed Tecentriq for 1st Line Lung Cancer in March as Players Race to Grab Low PD-L1 Expressers
  July 27, 2018

• Chugai Sees Solid Uptake for Tecentriq, Hemlibra but CEO Frets Pricing Stability
  July 27, 2018

• Dasotraline Demonstrates Significant Improvement in Binge Eating Disorder in US PIII Study: Sunovion
  July 27, 2018

• Elenbecestat Clears Brain Amyloid, Eisai/Biogen Reports Detailed PII Data
  July 26, 2018

• Alunbrig Beats Xalkori in Front-Line NSCLC: Takeda
  July 26, 2018

• (Update) Eisai/Biogen Alzheimer’s Drug BAN2401 Slows Cognitive Decline by 30%
  July 26, 2018

• Astellas Is Best Pharma Company to Work for: Survey
  July 26, 2018

• 2 Major Japan Wholesalers Hook Up on Specialty, Generic Drug Biz
  July 25, 2018

• Solasia Grabs China Approval for Antiemetic Patch Drug
  July 25, 2018

• Oncologist Lauds Imfinzi as Trailblazer in Stage III Lung Cancer, Eagerly Awaiting OS Data
  July 24, 2018

• Sales Reps Required Spontaneous Safety Reports even in Surveys Using Database: Ms Takizawa of Otsuka
  July 24, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 377
• 378
• 379
• 380
• 381
• 382
• 383
• 384
• 385
• …
• Next ›
• 最終 »